Business · 03/09/2010Updated: 10/17/2026 · 1 min read
FDA Approves Injectable Treatment for Bovine Respiratory Disease
Summary
The FDA is updating its regulations to reflect the approval of a new treatment for bovine respiratory disease, which is now approved for use against Mycoplasma bovis, following a supplemental application by Intervet, Inc.
Original source language: Federal Register — Health and Human ServicesOpen original release →